Nureca Limited (NSE:NURECA)
286.65
-3.25 (-1.12%)
Jul 11, 2025, 3:29 PM IST
Nureca Revenue
In the fiscal year ending March 31, 2025, Nureca had annual revenue of 1.10B INR with 19.29% growth. Nureca had revenue of 317.40M in the quarter ending March 31, 2025, with 87.04% growth.
Revenue
1.10B
Revenue Growth
+19.29%
P/S Ratio
2.61
Revenue / Employee
6.41M
Employees
171
Market Cap
2.87B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1.10B | 177.33M | 19.29% |
Mar 31, 2024 | 919.28M | -193.95M | -17.42% |
Mar 31, 2023 | 1.11B | -1.44B | -56.44% |
Mar 31, 2022 | 2.56B | 420.94M | 19.72% |
Mar 31, 2021 | 2.13B | 1.14B | 114.69% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 272.67B |
Mankind Pharma | 122.07B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Glenmark Pharmaceuticals | 134.35B |
Nureca News
- 3 months ago - Nureca shares jump over 3% as Dr Trust & Dr Physio gear up to launch on Swiggy Instamart - Business Upturn
- 10 months ago - Nureca shares surge 6% after company signs distribution agreement - Business Upturn